We are live on ! Find out more
OGC

One68 Global Capital Portfolio holdings

AUM $30.9M
This Fund
S&P 500
This Quarter Est. Return
+29.58%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$49.8M
AUM Growth
+$12.1M
Cap. Flow
+$9.46M
Cap. Flow %
18.99%
Top 10 Hldgs %
44.63%
Holding
139
New
99
Increased
4
Reduced
13
Closed
20

Sector Composition

Rank Sector Weight
1 Technology 28.7%
2 Healthcare 23.76%
3 Financials 15.51%
4 Communication Services 5.92%
5 Consumer Discretionary 5.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMD icon
26
Advanced Micro Devices
AMD
$776B
$477K 0.96%
+5,200
New +$449K
CCIV.U
27
DELISTED
Churchill Capital Corp IV Units, each consisting of one share of Class A common stock and one-fifth
CCIV.U
$471K 0.95%
+45,706
New +$458K
RBAC.U
28
DELISTED
RedBall Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one
RBAC.U
$470K 0.94%
+40,700
New +$447K
GDRX icon
29
GoodRx Holdings
GDRX
$1.04B
$432K 0.87%
+10,708
New +$492K
GILD icon
30
Gilead Sciences
GILD
$162B
$408K 0.82%
7,000
-3,000
-30% -$181K
ACEVU
31
DELISTED
ACE Convergence Acquisition Corp
ACEVU
$386K 0.77%
+35,403
New +$362K
UPH
32
DELISTED
UpHealth, Inc.
UPH
$363K 0.73%
3,319
-244
-7% -$25.1K
VTRS icon
33
Viatris
VTRS
$20.4B
$331K 0.66%
+17,644
New +$288K
CHPM
34
DELISTED
CHP Merger Corp. Class A Common Stock
CHPM
$318K 0.64%
+30,957
New +$314K
FTOC
35
DELISTED
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
$308K 0.62%
+29,871
New +$294K
ELAN icon
36
Elanco Animal Health
ELAN
$13.2B
$307K 0.62%
+10,000
New +$305K
KSU
37
DELISTED
Kansas City Southern
KSU
$306K 0.61%
+1,500
New +$282K
CTEV
38
Claritev Corp
CTEV
$387M
$290K 0.58%
+907
New +$302K
GLS
39
DELISTED
Gelesis Holdings, Inc.
GLS
$274K 0.55%
+27,000
New +$266K
CLGX
40
DELISTED
Corelogic, Inc.
CLGX
$274K 0.55%
3,541
-32,984
-90% -$2.47M
KSMTU
41
DELISTED
Kismet Acquisition One Corp Unit
KSMTU
$273K 0.55%
+26,000
New +$263K
BHC icon
42
Bausch Health
BHC
$2.58B
$270K 0.54%
13,000
-80,831
-86% -$1.51M
PRSP
43
DELISTED
Perspecta Inc. Common Stock
PRSP
$267K 0.54%
+11,100
New +$238K
ZNTEU
44
DELISTED
Zanite Acquisition Corp. Unit
ZNTEU
$263K 0.53%
+25,000
New +$255K
GNW icon
45
Genworth Financial
GNW
$3.76B
$248K 0.5%
65,700
-234,535
-78% -$964K
BEAT
46
DELISTED
BioTelemetry, Inc.
BEAT
$246K 0.49%
+3,413
New +$179K
NTP
47
DELISTED
Nam Tai Property Inc.
NTP
$244K 0.49%
+41,700
New +$223K
RIOT icon
48
Riot Platforms
RIOT
$7.63B
$227K 0.46%
+13,348
New +$88.7K
SRTA
49
Strata Critical Medical Inc
SRTA
$434M
$222K 0.45%
+20,000
New +$204K
BEEM icon
50
Beam Global
BEEM
$23.3M
$221K 0.44%
+2,998
New +$83.1K

Similar funds

One68 Global Capital's Q4 2020 Portfolio in Review

As of Q4 2020, One68 Global Capital held 139 positions worth $49.8M, up 32% from $37.7M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

One68 Global Capital deployed $9.46M of net new capital in Q4 2020, opening 99 new positions and adding to 4 existing holdings. Its largest new stake was National General Holdings Corp: 131,000 shares worth $4.48M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Acacia Communications Inc, an estimated $5.51M trimmed.

  • One68 Global Capital's largest Q4 2020 buy was National General Holdings Corp: 131,000 shares worth $4.48M.
  • One68 Global Capital added most to Virtusa Corporation in Q4 2020, an estimated $792K increase.
  • One68 Global Capital's biggest Q4 2020 reduction was Acacia Communications Inc, cutting an estimated $5.51M.
  • One68 Global Capital fully exited Immunomedics Inc in Q4 2020, selling an estimated $5.19M.
  • One68 Global Capital's ten largest holdings make up 45% of its $49.8M portfolio in Q4 2020.
  • One68 Global Capital opened 99 new positions and closed 20 in Q4 2020.
  • One68 Global Capital's portfolio value rose 32% quarter-over-quarter to $49.8M.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.